GuideLite is SPH’s subscription based product designed to help CCGs rapidly interpret NICE guidance, understand the local implications, and help to mitigate financial and reputational risk.
With these reports, the CCG will receive:
- A concise summary analysis of the key issues and implications arising from NICE Clinical Guideline releases with greatest relevance to CCG commissioning
- A clear indication of the strength and quality of evidence uncovered and considered by NICE behind each of the key recommendations, to support CCGs to make a fully informed commissioning policy decision
- A simple toolkit to enable the CCG to consider the impact of the guidelines on their current policies and also provide the basis for the necessary audit trail behind subsequent policy decisions
- An analysis (where possible) of the cost implications of potential policy change arising from the guidelines.
To find out more, see GuideLite, or get in touch. We’d be happy to discuss your requirements